KRAS Q61H Mutation Confers Cancer Cells with Acquired Resistance to SHP2 Inhibition
Saved in:
Main Authors: | Yi-Hui Song (Author), Xin-Yu Yang (Author), Bin Yu (Author) |
---|---|
Format: | Book |
Published: |
Georg Thieme Verlag KG,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KRAS mutations and endometriosis burden of disease
by: Natasha L Orr, et al.
Published: (2023) -
Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2
by: Jingjing Wu, et al.
Published: (2022) -
Targeting mutated KRAS in the first‐line therapy
by: Hideaki Ijichi
Published: (2024) -
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations
by: Timothy J. Bauler, et al.
Published: (2011) -
Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
by: Ye Li, et al.
Published: (2021)